<DOC>
	<DOCNO>NCT00897286</DOCNO>
	<brief_summary>This laboratory study look store tumor sample young patient brain tumor . Studying sample tumor tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer .</brief_summary>
	<brief_title>Study Stored Tumor Samples Young Patients With Brain Tumors</brief_title>
	<detailed_description>The overall objective non-therapeutic protocol identify molecular abnormality within prospectively treat pediatric CNS develop xenograft vitro model derive Atypical Teratoid Rhabdoid Tumors ( ATRT ) , Choroid Plexus Carcinomas ( CPC ) , Ependymoma high-grade glioma . The investigator characterize genome-wide mutation , expression epigenetic signature model compare primary tumor derive , thus create well-characterized invaluable resource research rare deadly pediatric brain tumor . This also provide important insight intratumoral heterogeneity , molecular abnormality may influence selective pressure drive evolution , tumor growth xenografts vitro . define relationship abnormality tumor histologic clinical characteristic . This objective achieve apply state-of-the-art DNA , RNA protein epigenome analysis tool study fresh frozen , fix cultured tumor cell xenograft . The establishment cell culture tumor sample also allow vitro vivo analysis tumor cell growth , signal therapeutic response .</detailed_description>
	<mesh_term>Medulloblastoma</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Ependymoma</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Rhabdoid Tumor</mesh_term>
	<criteria>Inclusion Criteria ATRT , CPC , medulloblastoma/PNET , ependymoma glioma CNS document local neuropathologist . Tumor may primary , progressive recurrent CNS tumor include brain and/or spine . For fresh tissue , case must process tissue final diagnosis available . If xenograft establish brain tumor later diagnose different histological subtype , store frozen viable cell potential future use . Although rare , patient ATRT may present primary renal CNS tumor . In instance sample collect kidney CNS tumor analysis available . Tumor may collect surgery prior histologic confirmation Age 21 year time initial diagnosis . Enrollment current version institution 's banking protocol Biological parent ( ) participant ( child ) whose tumor study protocol . These parent assign cohort P. The exclusion criterion apply cohort . Exclusion Criteria Diagnosis tumor outside central nervous system . Age great 21 year time diagnosis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>childhood atypical teratoid/rhabdoid tumor</keyword>
	<keyword>childhood choroid plexus tumor</keyword>
	<keyword>childhood medulloblastoma</keyword>
	<keyword>recurrent childhood medulloblastoma</keyword>
	<keyword>childhood infratentorial ependymoma</keyword>
	<keyword>childhood supratentorial ependymoma</keyword>
	<keyword>recurrent childhood ependymoma</keyword>
	<keyword>recurrent childhood supratentorial primitive neuroectodermal tumor</keyword>
	<keyword>untreated childhood supratentorial primitive neuroectodermal tumor</keyword>
	<keyword>glioma</keyword>
</DOC>